1. Home
  2. JANX vs FOIL Comparison

JANX vs FOIL Comparison

Compare JANX & FOIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$10.13

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Londian Wason New Energy Tech Inc. American Depositary Shares each representing five Ordinary Shares

FOIL

Londian Wason New Energy Tech Inc. American Depositary Shares each representing five Ordinary Shares

N/A

Current Price

$13.76

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
JANX
FOIL
Founded
2017
2001
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
JANX
FOIL
Price
$10.13
$13.76
Analyst Decision
Buy
Analyst Count
18
0
Target Price
★ $33.14
N/A
AVG Volume (30 Days)
★ 946.4K
35.7K
Earning Date
11-05-2026
12-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $10,000,000.00
N/A
Revenue This Year
$174.21
$68.46
Revenue Next Year
N/A
$10.88
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$10.16
$12.51
52 Week High
$35.34
$25.47

Technical Indicators

Market Signals
Indicator
JANX
FOIL
Relative Strength Index (RSI) 25.34 37.95
Support Level N/A $12.51
Resistance Level $14.47 $23.41
Average True Range (ATR) 1.16 1.32
MACD -0.48 0.04
Stochastic Oscillator 0.33 11.52

Price Performance

Historical Comparison
JANX
FOIL

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About FOIL Londian Wason New Energy Tech Inc. American Depositary Shares each representing five Ordinary Shares

Londian Wason New Energy Tech Inc is engaged in the research, development, and manufacture of electrolytic copper foil. Its product portfolio includes lithium-ion battery (LiB) copper foil, printed circuit board (PCB)-grade copper foil, and flexible copper clad laminates (FCCLs). Its products are used in applications including electric vehicles, energy storage systems, communication equipment, and consumer electronics. The company derives its revenue from contracts with customers, including the sales of LiB copper foil, PCB-grade copper foil and others in the PRC.

Share on Social Networks: